EGFR-IN-185

EGFR-IN-185 is a  EGFR  inhibitor. EGFR-IN-185 exhibits potent activity against non-small cell lung cancer (NSCLC) cells harboring EGFR mutations.  EGFR-IN-185 inhibits colony formation and migration,   induces G0/G1 arrest, and promots apoptosis, which are associated with the suppression of EGFR and AKT phosphorylation.  EGFR-IN-185 can be used for the research of    NSCLC[1].